NCT03108443Active, not recruiting
Novel Markers for Detecting Early Progression of Glaucoma
Source: ClinicalTrials.gov · Last updated 17 Feb 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Current methods of detecting glaucoma and monitoring its progression over time involve visual assessment of the optic nerve, thickness measurements of nerve tissue in the eye (using optical coherence tomography, OCT) as well as functional tests which measure peripheral, or side, vision. The objective of this study is to determine if a new technique of measuring blood flow in the eye, using OCT, can be used to better detect and/or monitor changes in glaucoma patients and suspects than these methods.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 250 (estimated)
- First submitted
- 5 Apr 2017
- Start date
- 1 Apr 2018
- Primary completion date
- 31 May 2026
- Lead sponsor
- Balwantray Chauhan
- Diseases
- Glaucoma
- NCT number
- NCT03108443
What you commit to
- Study type: Observational
- Planned participants: 250
- From 1 Apr 2018 to the primary completion date, 31 May 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- non-glaucomatous ocular disease
- chronic systemic disease or treatment affecting the visual field
- chronic ocular disease
- chronic systemic disease or treatment affecting the visual field
Other
- refraction exceeding 6 D equivalent sphere or 3 D astigmatism
- inability to provide informed consent
- Control Group
- refraction exceeding 6 D equivalent sphere or 3 D astigmatism
- inability to provide informed consent
Who the study is looking for
- visual acuity ≥ 6/12
- glaucomatous ONH change
- glaucomatous visual field loss with a positive Glaucoma Hemifield Test
- visual acuity ≥ 6/12
- normal eye examination with intraocular pressure ≤ 21 mm Hg
- normal visual field and negative Glaucoma Hemifield Test
Criteria the registry did not label
- Glaucoma Group
Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Eye Care Centre Coordinator of this site? Confirm its status | Halifax | Canada | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.